Table 5 Risk factors for infection by antibiotic-resistant organisms in HAP group
From: Microbiological analysis of nosocomial pneumonia at Tanta University Chest Hospital
Variable in HAP (N = 50) | Antimicrobial susceptibility test | Chi-square | ||||
|---|---|---|---|---|---|---|
Sensitive | Resistant | |||||
N | % | N | % | Χ2 | p-value | |
Immunosuppressive drugs | 1 | 2.78 | 2 | 14.29 | 2.367 | 0.124 |
Systemic steroid therapy | 9 | 25.00 | 6 | 42.86 | 1.531 | 0.216 |
Inhaled steroid therapy | 29 | 80.56 | 11 | 78.57 | 0.025 | 0.875 |
Hospitalization of > 2 days in last month | 2 | 5.56 | 4 | 28.57 | 5.057 | 0.025* |
Hospitalization of ≥ 5 days prior NP occurrence | 18 | 50.00 | 11 | 78.57 | 3.378 | 0.066 |
Intravenous antibiotic use within last 3Â months | 8 | 22.22 | 10 | 71.43 | 10.593 | 0.001* |